| Dexus Convenience Retail REIT (DXC) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$409 |
Update - Notification of buy-back - DXC
|
29 Jan 2025 9:38AM |
$2.810 |
$2.970 |
risen by
5.69%
|
|
| Veris Limited (VRS) ORDINARY FULLY PAID |
Industrials |
$34 |
Trading Halt
|
29 Jan 2025 9:37AM |
$0.040 |
$0.065 |
risen by
62.50%
|
|
VRS - Price-sensitive ASX Announcement
Full Release
Key Points
- Securities of Veris Limited placed in trading halt.
- Request for halt pending announcement of a material acquisition.
- Trading halt effective immediately.
- Halt will remain until January 31, 2025, or announcement release.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Global Lithium Resources Limited (GL1) ORDINARY FULLY PAID |
Materials |
$58 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jan 2025 9:36AM |
$0.203 |
$0.223 |
risen by
9.88%
|
|
GL1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Manna Lithium Project remains the top priority.
- Ongoing challenges in lithium market conditions.
- Completion of key Definitive Feasibility Study work.
- Exploration activities suspended until market conditions improve.
- Cash position of $18.9 million as of December 31, 2024.
- Acquisition of Talga Project expands exploration potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alpha HPA Limited (A4N) ORDINARY FULLY PAID |
Materials |
$1,006 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2025 9:35AM |
$0.870 |
$0.885 |
risen by
1.72%
|
|
A4N - Price-sensitive ASX Announcement
Full Release
Key Points
- Bulk earthworks for HPA First Project completed on time and budget.
- Secured $400 million senior debt funding package.
- Design progression reached 30% engineering level.
- Final permit amendment approval received.
- WHS accreditation achieved for construction.
- Production Tax Credit review initiated.
- Significant orders for semiconductor sector exceeding 5,000 kg.
- New high-purity alumina product developed for semiconductor demand.
- Technical Acceptance Letter received for anode coating.
- Strong demand in the DLE sector and successful ATH granules development.
- $30 million facility extended for Alpha Sapphire project.
- Adoption of GaN-on-sapphire semiconductors accelerating.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Neurotech International Limited (NTI) ORDINARY FULLY PAID |
Health Care |
$17 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2025 9:35AM |
$0.048 |
$0.016 |
fallen by
66.67%
|
|
NTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Neurotech continues to provide NTI164 to patients with Autism Spectrum Disorder and reports no safety concerns.
- The FDA granted orphan drug designation for NTI164 in Rett Syndrome, enhancing efforts for regulatory approval.
- Genomic analyses show NTI164 reverses immune dysregulation in PANDAS/PANS patients.
- The company anticipates receiving approximately $2.45 million from R&D tax incentives in February 2025.
- Neurotech recorded total cash operating expenses of $2.8 million for the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lykos Metals Limited (LYK) ORDINARY FULLY PAID |
Materials |
- |
Operational update
|
29 Jan 2025 9:34AM |
$0.010 |
$0.033 |
risen by
230%
|
|
LYK - Price-sensitive ASX Announcement
Full Release
Key Points
- Lykos Metals Limited updated shareholders on its projects in Bosnia and Herzegovina.
- The tenement application size for the Sockovac project was reduced from 44 km² to 10 km².
- The Jezero exploration permit was extended until March 2028.
- Channel sampling revealed surface mineralization including 61 meters at 1.5 g/t gold.
- Lykos is exploring potential acquisitions to enhance shareholder value.
- The company is considering various opportunities for capital raising.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RAM Essential Services Property Fund (REP) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$303 |
Update - Notification of buy-back - REP
|
29 Jan 2025 9:34AM |
$0.580 |
$0.605 |
risen by
4.31%
|
|
| Lion Energy Limited (LIO) ORDINARY FULLY PAID |
Energy |
$5 |
Quarterly Activities Report
|
29 Jan 2025 9:34AM |
$0.018 |
$0.012 |
fallen by
33.33%
|
|
LIO - Price-sensitive ASX Announcement
Full Release
Key Points
- Lion continues the development phase of the Port of Brisbane Green Hydrogen Project with DGA Energy Solutions and Samsung C&T.
- Key hydrogen offtake discussions are ongoing with a major marketing push starting.
- New seismic data confirms the potential of the Kobi and Waru prospects in the East Seram PSC.
- Planning for a well at the Kobi-1 prospect is underway with drilling scheduled for 2026.
- Gross crude oil production from the Seram PSC was 78,031 bbls, with an average daily production of 848 bopd.
- Lion completed a crude oil lifting of 160,440 bbls at a selling price of US$56.264/bbl.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bank of Queensland Limited (BOQ) ORDINARY FULLY PAID |
Financials |
$5,126 |
APRA Basel III Pillar 3
|
29 Jan 2025 9:34AM |
$6.900 |
$7.750 |
risen by
12.32%
|
|
| Cokal Limited (CKA) ORDINARY FULLY PAID |
Materials |
$33 |
Joint Venture Facilitating Ramp-up of BBM Coal Production
|
29 Jan 2025 9:34AM |
$0.060 |
$0.031 |
fallen by
48.33%
|
|
CKA - Price-sensitive ASX Announcement
Full Release
Key Points
- Cokal and Cratus are advancing their Strategic Partnership.
- The Infrastructure Joint Venture aims to enhance coal transport capacity.
- Development milestones have been achieved towards increasing coal transport capacity.
- Two self-propelled coal vessels have been obtained for initial operations.
- The IJV will build additional vessels tailored to Cokal's requirements.
- Krajan Jetty is set for upgrades to accommodate new vessels.
- The project aims to reduce the FOB cost per tonne of coal produced.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brazilian Rare Earths Limited (BRE) ORDINARY FULLY PAID |
Materials |
$255 |
Vesting of Options
|
29 Jan 2025 9:33AM |
$2.270 |
$2.260 |
fallen by
0.44%
|
|
| Victory Metals Limited (VTM) ORDINARY FULLY PAID |
Materials |
$170 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Jan 2025 9:33AM |
$0.350 |
$1.480 |
risen by
322.86%
|
|
VTM - Price-sensitive ASX Announcement
Full Release
Key Points
- Strategic Offtake MOU signed with Sumitomo Corporation.
- Victory to provide Sumitomo 30% of annual MREC production.
- Initial 5-Year Offtake Term with possibility for extension.
- Mineral Resource Estimate upgraded to 247.5 million tonnes at 520 ppm TREO.
- High-grade near surface zone now totals 53 million tonnes at 1,012 ppm TREO.
- Consistent high Heavy Rare Earth Oxide to TREO ratios established.
- Scandium resource increased, anticipating rising demand.
- North Stanmore Project strike length expanded to 13.5 km.
- Company remains well-funded with $4.85 million in cash.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Shine Justice Ltd (SHJ) ORDINARY FULLY PAID |
Consumer Discretionary |
$110 |
FY25 Half Year Results Announcement Date
|
29 Jan 2025 9:33AM |
$0.770 |
$0.645 |
fallen by
16.23%
|
|
| Lowell Resources Fund (LRT) ORDINARY UNITS FULLY PAID |
Financials |
$60 |
LRT NAV Estimate - 24 January 2025
|
29 Jan 2025 9:32AM |
$1.105 |
$1.450 |
risen by
31.22%
|
|
| Lion Energy Limited (LIO) ORDINARY FULLY PAID |
Energy |
$5 |
Quarterly Cashflow Report
|
29 Jan 2025 9:31AM |
$0.018 |
$0.012 |
fallen by
33.33%
|
|
LIO - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash from operating activities was negative at $231,000.
- Cash and cash equivalents at the end of the quarter totaled $1,920,000.
- Payments to related parties amounted to $180,000.
- The report includes details on financing facilities, including a convertible note.
- The company expects to continue operations with the current cash flow.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Dexus Industria REIT (DXI) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$923 |
Update - Notification of buy-back - DXI
|
29 Jan 2025 9:31AM |
$2.700 |
$2.910 |
risen by
7.78%
|
|
| Australian Vanadium Limited (AVL) ORDINARY FULLY PAID |
Materials |
$95 |
Green Energy Major Project Status Granted
|
29 Jan 2025 9:30AM |
$0.014 |
$0.011 |
fallen by
21.43%
|
|
AVL - Price-sensitive ASX Announcement
Full Release
Key Points
- The Australian Vanadium Project has been selected as a lead agency advice and support project.
- The Lead Agency framework focuses government efforts on projects aligned with decarbonisation and economic diversification.
- The project will unlock domestic vanadium production and support AVL's strategy for energy storage.
- AVL aims to efficiently secure approvals and drive local job creation.
- The project includes an open-cut vanadium mine and concentrator at Gabanintha and a processing plant at Tenindewa.
- AVL's strategy aligns with the Australian Government's 'Future Made in Australia' plan.
- AVL is committed to advancing approvals and project development for long-term value creation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rox Resources Limited (RXL) ORDINARY FULLY PAID |
Materials |
$228 |
Application for quotation of securities - RXL
|
29 Jan 2025 9:28AM |
$0.230 |
$0.305 |
risen by
32.61%
|
|
| Strata Minerals Limited (SMX) ORDINARY FULLY PAID |
Materials |
$4 |
Drilling to Commence at Penny South Gold Project
|
29 Jan 2025 9:26AM |
$0.033 |
$0.015 |
fallen by
54.55%
|
|
SMX - Price-sensitive ASX Announcement
Full Release
Key Points
- Maiden drilling program at Penny South Gold Project to commence mid-February 2025.
- 13 reverse circulation holes planned, targeting high-grade extensions from nearby gold deposits.
- Drilling contract awarded to Topdrill Pty Ltd.
- Located approximately 550m south of the Penny West and Penny North deposits.
- Initial assay results expected in March/April 2025.
- Strategic review for Biranup Gold Project ongoing with high priority targets identified.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rox Resources Limited (RXL) ORDINARY FULLY PAID |
Materials |
$228 |
Completion of Tranche 2 Placement and Cleansing Statement
|
29 Jan 2025 9:26AM |
$0.230 |
$0.305 |
risen by
32.61%
|
|
| Anax Metals Limited (ANX) ORDINARY FULLY PAID |
Materials |
$6 |
Scaled Up Column Testwork Confirms Bioleaching Technology
|
29 Jan 2025 9:26AM |
$0.010 |
$0.007 |
fallen by
30%
|
|
ANX - Price-sensitive ASX Announcement
Full Release
Key Points
- Bacterial leaching test work on scaled up columns delivers 77-80% copper extraction and over 90% zinc extraction.
- Heap leaching technology is increasingly sought after globally, targeting over 70% copper recovery.
- Anax has completed a four-year bioleaching technology development program with CSIRO.
- Consistent results from scaling up increase confidence in bioleaching potential at Whim Creek.
- Zinc leaching results exceed expectations, presenting potential new business opportunities.
- The bioleaching technology may be applied to other ores in the Pilbara region.
- The Anax flowsheet maximizes production capacity and flexibility for consolidation strategies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| American Rare Earths Limited (ARR) ORDINARY FULLY PAID |
Materials |
$207 |
Halleck Creek Resource expands to 2.63 billion tonnes
|
29 Jan 2025 9:25AM |
$0.275 |
$0.370 |
risen by
34.55%
|
|
ARR - Price-sensitive ASX Announcement
Full Release
Key Points
- Halleck Creek Total Mineral Resource Estimate increased by 12.2% to 2.63 billion tonnes at 3,926 ppm TREO.
- Red Mountain Area within Halleck Creek saw a 29.7% growth in resources, increasing to 1.24 billion tonnes.
- Cowboy State Mine grew by 29.4% to 543 million tonnes, with a 2.7% increase in TREO grade.
- The deposit remains open at depth and along strike, offering significant upside potential.
- The project’s favorable geology supports efficient processing of rare earths.
- ARR aims to reduce U.S. reliance on imports and enhance economic security.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$773 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Jan 2025 9:25AM |
$1.130 |
$1.325 |
risen by
17.26%
|
|
PYC - Price-sensitive ASX Announcement
Full Release
Key Points
- PYC made material progress in all four drug development programs during Q4 2024.
- Received Orphan Drug Designation and Rare Pediatric Disease Designation for Retinitis Pigmentosa type 11.
- Commenced dosing in patients for Autosomal Dominant Optic Atrophy.
- Completed pre-clinical studies for Polycystic Kidney Disease and submitted for regulatory approval.
- Nominated a clinical development candidate for Phelan-McDermid Syndrome.
- Company ended the quarter with $49.3 million in cash and received a $17.3 million R&D tax rebate.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Franklin Australian Absolute Return Bond Fund (Managed Fund) (FRAR) |
Financials |
$690 |
Final Dividend Details 31 January 2025
|
29 Jan 2025 9:25AM |
$1.015 |
$1.045 |
risen by
2.96%
|
|
| Nova Eye Medical Limited (EYE) ORDINARY FULLY PAID |
Health Care |
$41 |
Trading Halt
|
29 Jan 2025 9:24AM |
$0.165 |
$0.145 |
fallen by
12.12%
|
|
EYE - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by Nova Eye Medical Limited.
- Halt is due to an announcement regarding capital raising.
- Trading halt effective from January 29, 2025.
- Halt will last until announcement or January 31, 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
